Private Firms’ IPO Issuance Examination Time and Its Economic Consequences

在中国资本市场中，IPO企业从申报上市到最终发行往往要经历漫长的审核过程。以2016年为例，过会的265家企业从申报到上市平均需要862天，其中主板企业887天，中小板企业915天，创业板企业798天，而对于少部分“不幸”的企业而言，审核时间更是长达四五年之久。令人困惑的是，尽管发行审核制度如此严格，新股市场上欺诈发行、业绩变脸、高管集体辞职套现等现象却屡见不鲜，这不禁让人对监管机构审核的有效性提出了质疑。为什么层层严格审核之后，新股乱象依然不止？审核时间长短与这些乱象之间是否存在某种关联？ 本文以2009-2012年上市的647家A股民营企业为研究样本，实证检验了审核时间与上市后表现之间的...Chinese IPO firms have to go through a time-consuming process of examination before listed in the stock market. The average examining time of IPO firms that were approved in 2016 by Chinese Issuance Examination Committee (IEC) is 863 days. To some “unfortunate” IPO firms, this process could take 4 or 5 years. However, after such vigorous examination process, incidents such as IPO fraud scandals, s...学位：会计硕士院系专业：管理学院_会计硕士学号：1842014115064

Rocket observations of O2 atmospheric (0-0) band, OH meinel bands and continuum emission in the night airglows

Thesis--University of Tsukuba, D.Sc.(B), no. 310, 1986. 3. 2

CLINICAL EXPERIENCE WITH TSAA-291 FOR BENIGN PROSTATIC HYPERTROPHY

Nineteen patients of benign prostatic hypertrophy in our clinic (Stage I 13, Stage II 6) were treated with 16β-ethyl-17 β-hydroxy-4-estren-3-one(TSAA-291 ), a new strong anti-androgenic agent developed by Takeda Chemical Industries, Ltd. 200 mg/week of TSAA-291 were injected for 11 -12 weeks. Residual urine, dysuria, urinary stream, straining and nycturia were examined as to clinical effect. Clinical findings improved in 14 of 19 cases. Side effects were found in two patients, one was malaise, another one was headache and palpitation. Abnormal change in hemogram, liver function, renal function and serum acid-phosphatase after injection of TSAA-291 were not observed. In conclusion, TSAA-291 can be used without detectable side effects for conservative treatment of some selected cases of benign prostatic hypertrophy

乳化すり身ゲルの物理的および化学的性質に関する研究

東京海洋大学博士学位論文 平成30年度(2018) 応用生命科学 課程博士 甲第492号指導教員: 岡﨑 惠美子東京海洋大学201